The aim of the study was to characterize endometrial mRNA transcription, immunolocalization, and protein expression of interleukin (IL) 1alpha, IL1beta, IL6, and IL1RI, IL1RII, and IL6Ralpha/beta in the course of endometrosis during the estrous cycle. Additionally, the influence of IL1alpha, IL1beta, and IL6 on prostaglandin (PG) secretion and PG synthase mRNA transcription in endometrial tissue during endometrosis was investigated. The endometrial samples were obtained at the early (n ¼ 12), mid-(n ¼ 12), and late (n ¼ 12) luteal phases and at the follicular (n ¼ 12) phase of the estrous cycle. Within each of these phases, there were four samples within each category I, II, and III of endometrium, according to the Kenney classification. In experiment 1, transcription of IL1alpha, IL1beta, IL6, and their receptor's (IL1RI, IL1RII, and IL6Ralpha/beta) mRNAs and their immunolocalization and protein expression were determined using real-time PCR and immunohistochemistry, respectively. In Experiment 2, endometrial samples (n ¼ 5 samples within categories I, II, and III) were obtained for tissue culture in the midluteal phase of the estrous cycle. The endometrial tissues were stimulated with IL1alpha (10 ng/ml), IL1beta (10 ng/ml), IL6 (10 ng/ml), and oxytocin (positive control; 10 À7 M) for 24 h. The PG concentration was determined using ELISA. In addition, transcription of PTGS-2, PGES, and PGFS mRNAs was determined using real-time PCR. ILs were found to regulate PG secretion via modulation of PG synthases in equine endometrium. The alterations in IL and the expression of their receptors, and in endometrial secretory functions, were observed during the course of endometrosis, and suggest serious changes in the endometrial microenvironment. The described disturbances may be closely related to impaired endometrial processes responsible for the subfertility or the infertility in endometrosis.
INTRODUCTION
Chronic endometrial degeneration, known as equine endometrosis, is associated with decreased fertility and early embryonic loss [1, 2] . This disease has been described as a progressive process involving periglandular and/or stromal fibrosis in the endometrium, as well as glandular alterations, such as cystic dilation, atrophy, or hypertrophy [1] . Although there is much information on histologic and ultrastructure alterations in the mare endometrium [1, [3] [4] [5] , and on the susceptibility of the endometrium to bacterial adhesion and infection [6, 7] , the pathophysiologic alterations during the course of endometrosis are not well understood. In fact, there are only a few studies reporting the endometrial secretory alterations during the course of endometrosis [2, 8, 9] . Alterations in transcription of prostaglandin (PG) synthase mRNA and PG concentration in equine endometrium simultaneous with endometrosis are suggested to have a negative impact on the adequacy of endometrial function [9] . We suggest that the main reason for embryo loss in the course of endometrosis is endometrial environment changes. Thus, the purpose of this study was to investigate how endometrial ILs and the expression their receptors change, and how these ILs affect PG secretion in the course of endometrosis. The rationale for assessing the response of endometrial tissue to ILs in midluteal phase is that this phase mimics the early pregnancy environment, when the horse embryo starts its transmigration from one uterine horn to the other, and the domination of progesterone (P 4 ) in the blood plasma is the highest. Our proposed model may give some insights in the disturbance between PG and ILs in the course of endometrosis, which could suggest a potential reason for implantation problems.
PGs play critical roles in many reproductive functions, such as ovulation, fertilization, maternal recognition of pregnancy, and implantation [10] . In the PG production cascade, the PGendoperoxide synthase (PTGS) enzyme converts arachidonic acid into PGH 2 [10, 11] . There are two isoforms of PTGS, designated PTGS-1, which is constitutively expressed, and PTGS-2, which is the inducible isoform. PGF 2a synthase (PGFS) and PGE 2 synthase (PGES) are downstream enzymes that catalyze the conversion of PGH2 into PGF 2a and PGE 2 , respectively.
Cytokines are signaling protein molecules that are secreted by numerous cells and act mostly in an autocrine/paracrine manner. Interleukin (IL) 1a and IL1b or IL6 are known to take part in regulation of the estrous cycle by modulation of PG synthesis in species other than the horse [12] [13] [14] [15] [16] . In particular, IL1a seems to be a potent luteotropic factor supporting early pregnancy development through stimulation of P 4 and PGE 2 production in the cow [14] . Nevertheless, there is almost no information about the role and expression of these cytokines during the estrous cycle or in the mare. Haneda et al. [17] showed that IL1 and IL6 mRNA transcription is up-regulated on Day 25 of pregnancy, suggesting a putative role of this cytokine during early pregnancy and embryo implantation in the mare. Additionally, these cytokines are known as modulators of the acute-phase inflammatory response that involves potent systemic and local effects.
The IL1 system consists of two agonists (IL1a and IL1b), an IL1 receptor antagonist (IL1RA), and two receptors known as IL1 receptor type I (IL1RI) and type II (IL1RII). Nonetheless, only IL1RI transduces a signal in response to IL1 [18] . IL6 is a pleiotropic cytokine, which is produced by different types of immune and nonimmune cells [19] . IL6 binds first to a low-affinity subunit called gp80 or IL6Ra on the surface of target cells. The IL6/IL6Ra complex recruits the signal-transducing subunits called gp130 or IL6Rb [19] .
The first aim of the study was to characterize the mare endometrial immunolocalization and mRNA transcription of IL1a, IL1b, IL6, and IL1RI, IL1RII, and IL6Ra/b during the course of endometrosis throughout the estrous cycle. The second aim of the study was to determine the influence of IL1a, IL1b, and IL6 on PG secretion and PG synthase mRNA transcription in endometrial tissue during the progress of endometrosis.
MATERIALS AND METHODS

Animals and Endometrial Tissue Collection and Treatments
Uteri (n ¼ 48) were collected postmortem from cyclic mares at a local abattoir. All procedures for animal treatment and tissue collection were approved by the local Animal Care and Use Committee in Olsztyn, Poland (Agreement No. 51/2011). The mares were healthy, as declared by official government veterinary inspection. The material was collected within 5 min of the death of the animal. Immediately before death, peripheral blood samples were collected into heparinized tubes (Monovettes-Sarstedt, Numbrecht, Germany) for subsequent P 4 and 17-b estradiol (E 2 ) analysis. The phases of the estrous cycle were identified based on P 4 and E 2 analysis of blood plasma and the macroscopic observation of ovaries [20] . The early luteal phase is characterized by the presence of corpora hemorrhagica and a blood plasma P 4 concentration . 1 ng/ml. At the midluteal phase, a well-developed corpus luteum (CL) is associated with follicles 15-20 mm in diameter and P 4 . 6 ng/ ml. At the late luteal phase, a regressing CL is present together with follicles 30-35 mm in diameter and a P 4 concentration of between 1 and 2.5 ng/ml. The follicular phase is characterized by absence of an active CL and the presence of a follicle .35 mm in diameter, with a P 4 concentration , 1 ng/ml [20] . The phases were also well differentiated by plasma E 2 , which was at a basal concentration in the luteal phase (around 2-10 pg/ml), but reaches values above 20 pg/ml in the follicular phase [21] .
The endometrial tissue was excised, rinsed with cold sterile RNAse-free saline solution, divided into two groups depending on the experimental design, and placed in: 1) 4% buffered formaldehyde for histological analysis after hematoxylin-eosin staining [20] or immunolocalization staining (immunohistochemistry [IHC]) for IL1a, IL1b, IL6, IL1RI, IL1RII, IL6Ra [22] or 2) RNAlater (#AM7021; Invitrogen, Burlington, ON, Canada) for IL1a, IL1b, IL6, IL1RI, IL1RII, IL6Rb mRNA transcription using real-time PCR.
For tissue culture, the uterine horns obtained at the midluteal phase were placed in sterile, incomplete (Ca 2þ -and Mg 2þ -free) Hanks balanced salt solution supplemented with gentamicin (20 lg/ml; Sigma-Aldrich, Madison, WI) and 0.1% bovine serum albumin (BSA; Sigma-Aldrich), kept on ice, and transported quickly to the laboratory.
To ensure that a sufficient number of mares would be available for each experimental group (see below), the endometrial samples were collected from April to July. Histological analysis was then done, and all endometria were classified microscopically as belonging to categories I, II, or III according to the Kenney classification [1] . Endometrium without degenerative alterations was graded as category I, while categories II and III corresponded to moderate and severe fibrosis, respectively [1] .
For Experiment 1, endometrial samples were obtained from mares at the early (n ¼ 12), mid (n ¼ 12), and late (n ¼ 12) luteal phases, and at the follicular phase (n ¼ 12) of the estrous cycle. Within each of these phases, there were four samples in each endometrium category I, II, and III. The determination of IL1a, IL1b, IL6, IL1RI, IL1RII, and IL6Rb mRNA transcription in the endometrial samples was performed using real-time PCR. The determination of IL1a, IL1b, IL6, IL1RI, IL1RII, and IL6Ra protein immunolocalization in the endometrial samples was performed using IHC staining.
For Experiment 2, endometrial samples were obtained from mares at the midluteal phase (n ¼ 15) of the estrous cycle. These samples corresponded to five samples of each endometrium category (I, II, and III). Explants of the endometrial tissue were minced into small pieces. Tissues (;50 mg) were washed three times in PBS containing gentamicin (20 lg/ll) and placed into culture tubes, each of which contained 1 ml Dulbecco modified Eagle medium (DMEM) without phenol red (Sigma-Aldrich) with 0.1% BSA and 10 000 U/ml penicillin G, 10 mg/ml streptomycin, and 25 lg/ml amphotericin B (antibiotic antimycotic solution; Sigma-Aldrich).
Tissue explants were preincubated on a shaker in a tissue incubator at 38.08C with 5% CO 2 in air for 6 h. Then, the medium was replaced with fresh DMEM supplemented with 0.1% BSA and antibiotics and antimycotic. Endometrial tissue was further incubated for 24 h. Moreover, cell viability of the endometrial explants was confirmed using Alamar Blue analysis according to the manufacturer's instructions (#DAL1025; Invitrogen).
The endometrial explants were exposed to IL1a (10 ng/ml), IL1b (10 ng/ ml), and IL6 (10 ng/ml) for 24 h. Oxytocin (OT; 10 7 M) was used as a positive control. Each treatment was performed in triplicate for each mare's samples. After incubation, the conditioned culture medium was collected in tubes with 5% EDTA and 1% acetylsalicylic acid solution (pH 3), and kept frozen at À208C until PG determination. In order to normalize the results, the concentration of PGE 2 and PGF 2a was assessed per 1 g of tissue. Additionally, after incubation, the endometrial strips were placed in RNAlater for the determination of PTGS-2, PGES, and PGFS mRNA transcription using realtime PCR.
Analytical Methods
Immunohistochemistry. The histological sections were immunostained for localization of IL1a, IL1b, IL6, and IL1RI, IL1RII, and IL6Ra proteins in endometrial tissue during the progress of endometrosis throughout the estrous cycle. The modified method described by Andronowska et al. [22] was used. Briefly, the sections were incubated with primary goat polyclonal antibodies against IL1a (anti-mouse; 15 lg/ml; #AF-400NA; R&D Systems), IL1b/IL1F2 (anti-equine; R&D System; #AF3340; 10 lg/ml), IL6 (anti-equine; 10 lg/ml; #AF1886; R&D Systems), IL6Ra (anti-mouse; 15 lg/ml; #AF1830; R&D Systems); IL1RI (anti-mouse; 5 lg/ml; #AF771; R&D Systems); IL1RII (antimouse; 15 lg/ml; #AF563; R&D Systems). The second anti-goat IgG antibody (Vectastain ELITE ABC KIT) was used according to the manufacturer's instructions. Negative controls were performed by replacing the primary antibody with goat polyclonal IgG (#AB-108-C; R&D Systems) or 0.1 M PBS (pH 7.4). IHC staining was assessed, with a light microscope (BX51; Olympus, Tokyo, Japan) at 203 magnification, as a characteristic brown staining, and tissue areas were photographed (DP11; Olympus).
Total RNA isolation and cDNA synthesis. Total RNA was extracted using the Total RNA Prep Plus Kit (A&A Biotechnology, Gdansk, Poland) according to the manufacturer's instructions. RNA samples were stored at À808C. Before use, RNA concentration and quality were determined spectrophotometrically and by agarose gel electrophoresis. The ratio of absorbance at 260 and 280 nm (A 260/280 ) was approximately 2. The RNA (1 lg) was reverse transcribed into cDNA using a ThermoScript RT-PCR System (Qiagen) according to the manufacturer's instructions. The cDNA was stored at À208C until real-time PCR was carried out.
Real-Time PCR. Real-time PCR was performed with ABI Prism 7300 sequence detection system using SYBR Green PCR master mix (Applied Biosystems, Foster City, CA). Based on gene sequences in GenBank (National Center for Biotechnology Information), the primers for IL1a, IL1b, IL6, IL1RI, IL1RII, and IL6Rb were designed using Primer Express 3.0 software (Applied Biosystems). The sequences for PTGS-2, PGES, PGFS, and SDHA primers were recently determined [9] . After a preliminary study, SDHA was chosen as the best housekeeping gene. All primers were synthesized by GenoMed (Warsaw, Poland). Primer sequences, expected PCR product lengths, and GenBank accession numbers of IL1RI, IL1RII, IL6Rb, and SDHA are reported in Table 1 . Total reaction volume was 20 ll containing: 1 ll cDNA (1 ng), 2 ll each forward and reverse primers (250 nM), and 10 ll SYBR Green PCR master mix. Real-time PCR was carried out as follows: initial denaturation (10 SZÓ STEK ET AL. min at 958C), followed by 40 cycles of denaturation (15 sec at 958C) and annealing (1 min at 608C). After each PCR reaction, melting curves were obtained by stepwise increases in temperature from 608C to 958C to ensure single-product amplification. The specificity of product was also confirmed by electrophoresis on 2% agarose gel. The data were analyzed using the method described by Zhao and Fernald [23] .
PG and ovarian steroids determination. Concentration of PGE 2 in the conditioned medium was determined using a PGE 2 EIA kit (#514010; Cayman Chemical, Ann Arbor, MI) according to the manufacturer's instructions. Concentrations of PGF 2a were determined using the direct enzyme immunoassay (EIA) method, as described previously [24] with modification. The standard curve for PGE 2 ranged from 16.5 to 1000 pg/ml. The intra-and interassay coefficients of variation (CVs) were 2.3% and 3.2%, respectively. The standard curve for PGF 2a ranged from 0.19 to 50 ng/ml and CVs were 2.5% and 3.8%, respectively. The concentration of P 4 in blood plasma was determined using EIA as described previously [25] . The standard curve for P 4 ranged from 0.0925 to 25 ng/ml, and CVs were 1.5% and 4.2%, respectively. The antibodies (Anti-P4, code SO/91/4; kindly donated by Dr. S. Okrasa, Warmia-Mazury University, Olsztyn, Poland) were characterized previously [26] .
The concentrations of E 2 in mare plasma were assayed by radioimmunoassay, after extraction with diethyl ether (extraction efficiency: 90%) as described previously [27] . The antibodies (Anti-E2, code BS/88/754; gift of Dr. B. Szafranska, Warmia-Mazury University, Olsztyn, Poland) were characterized previously [28] . The E 2 standard curve ranged from 0.5 to 80 pg/ml, and the effective dose for 50% inhibition of the assay was 1.98 pg/ml. The intraand interassay CVs averaged 5.3% and 6.5%, respectively.
Statistical Analysis
In Experiment 1, the statistical analyses of endometrial IL1a, IL1b, IL6, and IL1RI, IL1RII, IL6Rb mRNA transcription and the density of the immunohistochemical reaction were performed using two-way ANOVA followed by the Bonferroni multiple comparison test (GraphPad Software version 5; GraphPad, San Diego, CA). The data are shown as the mean 6 SEM of values obtained in four separate experiments. The results were considered significantly different when P , 0.05.
In Experiment 2, statistical analysis of the influence of IL on PG secretion from endometrial tissue was performed using parametric one-way ANOVA followed by a Newmann-Keuls comparison test. The effect of OT (positive control) on PG secretion was determined by Student t test. The data are shown as the mean 6 SEM of values obtained in five separate experiments, each performed in triplicate. The statistical analysis of IL influence on PG synthase mRNA transcription in endometrial tissue was performed using nonparametric one-way ANOVA Kruskal-Wallis followed by a Dunn test. The data are shown as the mean 6 SEM of values obtained in five separate experiments, each performed in triplicate. The results were considered significantly different at P , 0.05. In category I endometrium, IL1a mRNA transcription was up-regulated in the follicular phase, while in category II it was up-regulated in the late luteal phase, compared to other phases of the estrous cycle (P , 0.05; Fig. 2A ). However, in category III endometrium, IL1a mRNA transcription was downregulated in the late luteal phase (P , 0.05; Fig. 2A ). In fact, when compared to the other endometria, IL1a mRNA transcription in category III endometrium was the lowest in the late luteal phase compared to all other phases (P , 0.05; Fig. 2A ). Nevertheless, in category II endometrium, IL1a mRNA transcription was up-regulated in the late luteal phase compared to categories I and II endometria in the same estrous phase (P , 0.01; Fig. 2A ). In category I endometrium, the density of the immunohistochemical reaction for IL1a increased in the follicular phase compared to other phases of the estrous cycle (P , 0.05; Fig. 2B ). Additionally, in category II endometrium, the density of the immunohistochemical reaction for IL1a increased in the late luteal phase compared to category I endometria in the same estrous phase (P , 0.01; Fig. 2B ). In category III endometrium, the density of the immunohistochemical reaction for IL1a increased in the early and midluteal phase compared to category I endometria in the same estrous phase (P , 0.05; Fig. 2B ).
RESULTS
Experiment
In category I endometrium, IL1b mRNA transcription was down-regulated at the midluteal phase compared to other estrous cycle phases (P , 0.05; Fig. 3A) , while in category II endometrium it was up-regulated in the early luteal phase (P , 0.05; Fig. 3A) . Additionally, in category II endometrium, transcription was up-regulated in the early and midluteal phases compared to the other endometria in the same phases (P , 0.05; Fig. 3A ). In the presence of severe endometrosis (category III endometrium), IL1b mRNA transcription was down-regulated in the midluteal phase with respect to the early 
, and IL6Ra (IL-6a; P, R, S) in endometrial tissue in category I (first column; no degenerative changes) and category III (second and third column; severe endometrosis) endometrium during the estrous cycle. The negative controls are shown in T, U, and V. GE, glandular epithelium; GN, glandular nests; LE, luminal epithelium; S, stromal cells. Bar ¼ 100 lm (original magnification 320 for first and second column) and 50 lm (original magnification 340 for third column).
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and follicular phases (P , 0.05, P , 0.001; Fig. 3A ). In category I endometrium, the density of the immunohistochemical reaction for IL1b decreased in the midluteal phase compared to other phases of the estrous cycle (P , 0.05; Fig. 3B ). In category II endometrium, the density of the immunohistochemical reaction for IL1b increased in the early luteal phase compared to the other phase of the estrous cycle (P , 0.05; Fig. 3B ). Furthermore, in category III endometrium, the density of the immunohistochemical reaction for IL1b increased in the early luteal phase and the follicular phase compared to other phases of the estrous cycle (P , 0.05; Fig.  3B ). In category II endometrium, the density of the immunohistochemical reaction for IL1b increased in the early and midluteal phases compared to the other endometria in the same phases (P , 0.05; Fig. 3B ).
Regarding the IL receptors studied, in category II endometrium, IL1RI mRNA transcription was up-regulated in the early luteal and follicular phases of the estrous cycle compared to the other phases (P , 0.01; Fig. 4A ). In severe endometrosis, IL1RI mRNA transcription was up-regulated in the follicular phase compared to the early and midluteal phases of the estrous cycle (P , 0.05; Fig. 4A ). When comparing endometria with different degrees of fibrosis, IL1RI mRNA transcription was up-regulated in the early luteal and follicular phases in category II endometrium, with respect to category I and III endometria at the respective estrous phases (P , 0.05; Fig. 4A ). In category II endometrium, the density of the immunohistochemical reaction for IL1RI increased in the early luteal phase and in the follicular phase of the estrous cycle (P , 0.05; Fig. 4B ), while, in category III endometrium, it was only stronger in the follicular phase when compared to the other estrous phases (P , 0.05; Fig. 4B) . Additionally, the increase in ILRI staining in category II endometrium was observed in the early luteal and follicular phases compared to the other endometria in the same phases (P , 0.05; Fig. 4B ).In Statistical differences between phases of the estrous cycle in Kenney category III. Asterisks indicate statistical differences between IL1b mRNA transcription and the density of the immunohistochemical reaction during the course of endometrosis within each phase of the estrous cycle (*P , 0.05; **P , 0.01).
INTERLEUKIN IN EQUINE ENDOMETROSIS
category II endometrium, IL1RII mRNA transcription was down-regulated in the midluteal phase compared to the other phases of the estrous cycle (P , 0.01; Fig. 5A ). In addition, IL1RII mRNA transcription was down-regulated in the midluteal phase compared to IL1RII mRNA transcription in category I and III endometria at the respective estrous cycle phases (P , 0.05; Fig. 5A ). In severe endometrosis (category III endometrium), IL1RII mRNA transcription was downregulated in the late luteal phase compared to the other phases (P , 0.05, P , 0.05, P , 0.01; Fig. 5A ) and when compared to category I and II endometria at the respective estrous cycle phases (P , 0.01, P , 0.001, respectively; Fig. 5A ). Additionally, IL1RII mRNA transcription in category III was up-regulated in the follicular phase compared to categories I and II endometria (P , 0.001; Fig. 5A ). In category II endometrium, the density of the immunohistochemical reaction for IL1RII increased in the late luteal phase of the estrous cycle (P , 0.05; Fig. 5B ), while, in category III endometrium, it was the highest in the follicular phase compared to the other estrous phases (P , 0.05; Fig. 5B ). Additionally, in category II endometrium, IL1RII staining was increased in the late luteal phase with respect to the other endometria in the same phases (P , 0.05; Fig. 5B ), and in category III endometrium in the follicular phase (P , 0.05; Fig. 5B ).
Endometrial IL6 and IL6Ra mRNA transcription and immunolocalization. Immunolocalization of IL6 (Fig. 1, G-I) and IL6Ra ( Fig. 1, P , R, S) protein revealed their presence in luminal and glandular epithelial cells and in stromal cells. All proteins were localized in all three Kenney endometrium categories, regardless of the phase of the estrous cycle. The expression was more intense in luminal and glandular epithelial cells than in stromal cells.
In category I endometrium, IL6 mRNA transcription was up-regulated in the midluteal and follicular phases compared to the other phases of the estrous cycle (P , 0.05; Fig. 6A ). In category II endometrium, IL6 mRNA transcription was increased in the early luteal and follicular phases (P , 0.05, P , 0.01; Fig. 6A ), while, in category III endometrium, it was up-regulated in the follicular phase compared to the early and late luteal phases (P , 0.01; Fig. 6A ). Moreover, in category II endometrium, IL6 mRNA transcription was up-regulated in the Statistical differences between phases of the estrous cycle in Kenney category II.
x,y,z Statistical differences between phases of the estrous cycle in Kenney category III. Asterisks indicate statistical differences between ILRII mRNA transcription and the density of the immunohistochemical reaction during the course of endometrosis within each phase of the estrous cycle (*P , 0.05; **P , 0.01; ***P , 0.001).
SZÓ STEK ET AL. early luteal and follicular phases compared to category I and II endometria at the respective estrous cycle phases (P , 0.05, P , 0.01, P , 0.001, and P , 0.01, respectively; Fig. 6A ). In category I endometrium, the density of the immunohistochemical reaction for IL6 was increased in the midluteal phase compared to the other phases of the estrous cycle (P , 0.05; Fig. 6B ), while, in category II endometrium, it was increased in the early luteal and follicular phase (P , 0.05; Fig. 6B ). However, in category III endometrium, the density of the immunohistochemical reaction for IL6 was decreased in the early luteal phase compared to the others phases of the estrous cycle (P , 0.05; Fig. 6B ). In category II endometrium, the density of the immunohistochemical reaction for IL6 protein expression was increased in the early luteal phase compared to category I and III endometrium at the same estrous cycle phases (P , 0.05, P , 0.01; Fig. 6B ). On the other hand, in category II endometrium in the follicular phase, the density of the immunohistochemical reaction for IL6 was increased compared to the category I endometrium at the same estrous cycle phase (P , 0.05; Fig. 6B ).
In category II endometrium, IL6Rb mRNA transcription was down-regulated in the late luteal phase compared to the follicular phase of the estrous cycle (P , 0.05; Fig. 7A ). In contrast, in category III endometrium, IL6Rb mRNA transcription was up-regulated in the late luteal and follicular phases with respect to the early luteal phase (P , 0.05; Fig. 7A ). Additionally, in category II endometrium, IL6Rb mRNA transcription was increased in the early and midluteal phases in comparison to category I and III endometria in the respective estrous cycle phases (P , 0.05; Fig. 7A ). In category III endometrium, IL6Rb mRNA transcription was down-regulated in the late luteal phase compared to the other category endometria in the same phase (P , 0.05; Fig. 7A ). Furthermore, IL6Rb mRNA transcription was decreased in the follicular phase when compared to category I and II endometria (P , 0.001, P , 0.05; Fig. 7A ). In category II endometrium, the density of the immunohistochemical reaction for IL6Ra increased in the early luteal phase (P , 0.05; Fig.  7B ), while, in category III endometrium, it was weaker in the midluteal phase (P , 0.05; Fig. 7B ) when compared to the other estrous phases. The increase in IL6Ra staining in category II endometrium was in the early luteal phase in comparison to category I and III endometria in the respective estrous cycle phases (P , 0.05; Fig. 7B ). Additionally, in category III endometrium, the density of the immunohistochemical reaction for IL6Ra decreased in the early luteal phase Statistical differences between phases of the estrous cycle in Kenney category III. Asterisks indicate statistical differences between IL6Ra mRNA transcription and the density of the immunohistochemical reaction during the course of endometrosis within each phase of the estrous cycle (*P , 0.05; **P , 0.01; ***P , 0.001).
in comparison to category I endometrium in the respective estrous cycle phase (P , 0.001; Fig. 7B ). In category III endometrium, the density of the immunohistochemical reaction for IL6Ra decreased in the mid-and late luteal and follicular phases compared to other phases of the estrous cycle (P , 0.01; Fig. 7B ). 2 and PGF 2a from endometrial tissue in the respective category I (P , 0.01), and in category III was lower compared to secretion of PGE 2 and PGF 2a from endometrial tissue in the respective category I (P , 0.5).
OT (positive control) increased PGE 2 secretion from endometrial explants in category I (P , 0.05), in category II (P , 0.001), and in category III (P , 0.05) in comparison to the respective control groups (Fig. 8) . IL1a increased PGE 2 secretion from endometrial explants in categories I and III (P , 0.05) with respect to the control group (P , 0.05; Fig. 8 ). IL1b increased PGE 2 secretion from endometria in categories I (P , 0.001) and III (P , 0.05) compared to the respective control (P , 0.05; Fig. 8 ). IL6 raised PGE 2 secretion from endometrial tissue in categories I and III (P , 0.05), but lowered it in category II in relation to the control (P . 0.05; Fig. 8) .
With regard to PGF 2a secretion, it was increased by OT from all endometrial explants compared to the respective control group (P , 0.01; Fig. 9 ). IL1a increased PGF 2a secretion from endometrial explants in categories I and III compared to the respective control group (P , 0.05; Fig. 9 ). In addition, IL1b increased PGF 2a secretion from endometrial tissue in categories I (P , 0.05), II (P , 0.01), and III (P , 0.05; Fig. 9 ). IL6 increased PGF 2a secretion from endometrial tissue in categories I (P , 0.05), II (P , 0.05), and III (P , 0.01; Fig. 9 ).
Both IL1a and IL1b increased PTGS-2 mRNA transcription in category I and III endometrium (P , 0.05; Fig. 10 ), but had no effect on the other endometrium categories. In contrast, IL6 decreased PTGS-2 mRNA transcription in category II endometrium compared to the control (P , 0.01; Fig. 10 ).
All ILs increased PGES mRNA transcription in category I (P , 0.05; Fig. 11) , and IL1a and IL1b increased PGES mRNA also in category III endometrium (P , 0.05; Fig. 11) , when compared to the respective control. Nevertheless, in category II endometrium, IL1b decreased PGES mRNA transcription (P , 0.001; Fig. 11 ). IL6 decreased PGES mRNA transcription in category II endometrium compared to the control group (P , 0.05; Fig. 11 ).
An increase in PGFS mRNA transcription was observed as a result of incubating explants of endometrium categories I (P , 0.01; Fig. 12 ) and III with IL1a (P , 0.001; Fig. 12) , and with IL1b and IL6 in all endometrium categories (P , 0.05; Fig. 12 ), compared to the control group (P , 0.05; Fig. 12 ) .   FIG. 8 . The influence of IL1a (IL-1a; 10 ng/ml), IL1b (IL-1b; 10 ng/ml), and IL6 (IL-6; 10 ng/ml) on PGE 2 in vitro secretion from midluteal phase endometrial explants. The endometrial explants were assigned to category I (A), II (B), and III (C) according to Kenney . All values are expressed as nfold change from the control. Asterisks indicate statistical differences between the groups (*P , 0.05; ***P , 0.001).
DISCUSSION
The pathophysiology of endometrosis is rather complex and not well understood. Early embryo loss is a recurrent clinical reproductive finding in mares suffering from endometrosis. A comprehensive understanding of endometrosis pathogenesis would probably prevent these losses. There is an increasing acceptance that the endometrial microenvironment is changed in the course of this disease [2, 8, 9] . Our present findings are in support of this statement. Additionally, alteration in endometrial proteins and carbohydrates in endometrosis was shown and found to be responsible for embryo nutrition disturbance [2] . We have shown that PG and IL presence and interaction differ in the endometrium with no pathological changes (category I) from endometrium in the course of endometrosis (categories II and III), which might cause endometrial microenvironmental changes. In our findings, we have shown an estrous cycle-dependent IL1a/IL1b or IL6 expression pattern in category I endometrium. However, those patterns changed sharply in categories II and III endometrium. 9 . The influence of IL1a (IL-1a; 10 ng/ml), IL1b (IL-1b; 10 ng/ml), and IL6 (IL-6; 10 ng/ml) on in vitro PGF 2a secretion from midluteal phase endometrial explants. The endometrial explants were assigned to category I (A), II (B), and III (C) according to Kenney . All values are expressed as nfold change from the control. Asterisks indicate statistical differences between the groups (*P , 0.05; **P , 0.01).
FIG. 10. The influence of IL1a (IL-1a; 10 ng/ml), IL1b (IL-1b; 10 ng/ml), and IL6 (IL-6; 10 ng/ml) on PTGS-2 mRNA transcription in midluteal phase endometrial explants incubated in vitro. The endometrial explants were assigned to category I (A), II (B), and III (C) according to Kenney. Asterisks indicate statistical differences between the groups (*P , 0.05; **P , 0.01; ***P , 0.001).
We suggest that these changes weaken local events occurring in the endometrium that might likewise affect ovarian function.
Analysis of IL and the expression of their receptors during establishment of endometrosis did not show well-defined and explicit reasons for their alterations. They may be a result of several factors: the severity of this disease, the effect of ovarian steroids, individual characteristics of the mares, and the degree of inflammation or different hormonal regulation of glandular function in glandular nests during the estrous cycle. It should be taken into consideration that the increase in endometrial IL expression during the development of fibrosis may be connected with the role of IL in the pathogenesis of fibrosis, which was shown in other types of tissues [29] . IL1b inhibits synthesis of collagen by human dermal fibroblasts [30, 31] , FIG. 11 . The influence of IL1a (IL-1a; 10 ng/ml), IL1b (IL-1b; 10 ng/ml), and IL6 (IL-6; 10 ng/ml) on PGES mRNA transcription in midluteal phase endometrial explants incubated in vitro. The endometrial explants were assigned to category I (A), II (B), and III (C) according to Kenney. Asterisks indicate statistical differences between the groups (*P , 0.05; **P , 0.01; ***P , 0.001).
FIG. 12.
The influence of IL1a (IL-1a; 10 ng/ml), IL1b (IL-1b; 10 ng/ml), and IL6 (IL-6; 10 ng/ml) on PGFS mRNA transcription in midluteal phase endometrial explants incubated in vitro. The endometrial explants were assigned to category I (A), II (B), and III (C) according to Kenney. Asterisks indicate statistical differences between the groups (*P , 0.05; **P , 0.01; ***P , 0.001).
whereas it enhances fibroblast proliferation at sites of inflammatory reactions [32] . In turn, IL6 stimulates collagen production in humans [33, 34] .
Additionally, the alterations in PG secretion in response to IL during the course of endometrial fibrosis are not associated with impaired endometrial IL1RI and IL6Rb expression in the midluteal phase of the estrous cycle. Nevertheless, the pattern of PG synthase mRNA transcription in endometrial explants corresponds mostly with the response changes. These findings suggest that the changes in PG secretion in response to IL during the progress of endometrosis may be caused by the alterations in PTGS-2, PGES, and PGFS mRNA transcription.
Endometrial cyclic changes are complex processes governed by the interplay of several signaling pathways that have critical roles in endometrial events. The changes in endometrial microenvironment associated with changes in IL expression and secretory function may have several consequences if we look at them in a broader context. In fact, IL may be responsible for disturbances in physiological processes in endometrium, contributing to impairment of CL maintenance, cell proliferation, and angiogenesis during the estrous cycle, and to early embryo loss. Studies on the association of IL with PGs, in species other than the horse, showed that they may be among the most important components of physiological changes in estrous cycle regulation [12] [13] [14] [15] [16] . Furthermore, in the peri-implantation period, ILs participate in conducting several processes, including differentiation of endometrial cells and vascular endothelial cell changes, that accompany implantation and subsequent placental development.
Our results show that cytokines seem to be very important modulators of PG secretion in the mare. To the best of our knowledge, this is the first evidence that ILs may influence PG secretion and PG synthase mRNA transcription in the equine endometrium. The ability of ILs to stimulate PG secretion, in particular PGE 2 , may indicate their role in mechanisms regulating luteotropic and/or luteoprotective functions during the ovarian cycle and early pregnancy, as well as in angiogenesis and cell proliferation. This study showed that, in category I endometrium, IL1a increased PGE 2 secretion from endometrial explants up to about 4.7-fold, and PGF 2a only to 1.7-fold in the midluteal phase of the estrous cycle. Consistent with this, it has been shown that IL1a modulates PGE 2 and PGF 2a secretion from cow endometrial explants [12] . In cattle, PGE 2 secretion was stimulated in response to IL1a in the midluteal phase of the estrous cycle, while PGF 2a secretion was not altered at this phase [12] . In comparison to IL1a and IL6, IL1b had much more impact on PG production by the equine endometrium. This molecule seems to be a very important modulator of PG secretion. According to our results, in category I endometrium, IL1b increased PGE 2 secretion from endometrial explants to about 20-fold, and PGF 2a only to 2.5-fold in the midluteal phase of the estrous cycle. In the pig, IL1b increased PTGS-2 and mPGES mRNA transcription and PGE 2 secretion from endometrial explants in the midluteal phase of the estrous cycle [15] . In category I endometrium, IL6 increased PGE 2 secretion 3.5-fold, and PGF 2a secretion 2.3-fold. Moreover, IL6 stimulated PGES as well PGFS mRNA transcription. The results obtained by Franczak et al. [16] in the pig are in agreement with results obtained in this study. To summarize, it was shown that IL1a and IL1b stimulated potentially luteotropic PGE 2 secretion from equine endometrial explants in the midluteal phase of the estrous cycle. Perhaps this is one of the mechanisms that regulates uterine secretory functions, as well as supporting CL function and maintenance during the estrous cycle in the mare. However, it must be emphasized that, without in vivo data, these results do not allow for a clear definition of the role of IL in regulation of the ovarian cycle in the mare.
In the ewe, PGE 2 is considered to be an antiluteolytic and/or luteoprotective agent [35, 36] . In experiment conducted by Pratt et al. [35] , the catheter was inserted into each uterine horn that was ipsilateral to a CL in nonmated ewes on Day 11 postestrus. Intrauterine injections of PGE 2 caused a delay in a fall in P 4 concentration and lengthened the estrous cycle [35] . Magness et al. [36] determined that the intrauterine infusions of PGE 2 from Days 10 to 17 postestrus maintained luteal function after infusion into a uterine horn adjacent to a luteal-bearing ovary of unilaterally ovariectomized sheep with surgically separated uterine cornua. Vanderwall et al. [37] showed that uterine intraluminal administration of PGE 2 prolonged the CL life span in cyclic mares; nonpregnant mares were continuously infused with PGE 2 on Days 10 to 16 postestrus [37] . As a matter of fact, the up-regulation of equine endometrial PGES mRNA transcription and PGE 2 at the midluteal phase of the estrous cycle was confirmed in our previous work [9] . Additionally, we have shown that PGE 2 stimulated in vitro P 4 secretion from equine luteal steroidogenic cells [38] .
In light of our results in the cow, IL1a was considered as a luteotropic agent [14] . The infusion of IL1a into the cow uterine lumen increased P 4 and PGE 2 concentration in blood plasma, inhibiting spontaneous luteolysis and prolonging the life span of the bovine CL [14] . These luteotropic effects may result in appropriate development and function of the bovine CL during the estrous cycle and early pregnancy. However, it must be emphasized that, without in vivo data, these results do not allow for a clear definition of the role of IL in the regulation of the ovarian cycle in the mare.
PGs take part not only in regulation of estrous cycle, but also in autocrine/paracrine regulation of endometrial function (e.g., embryo implantation, angiogenesis, or cell proliferation). Angiogenesis is described as the development of microvessels from pre-existing blood vessels. Cyclic endometrial tissue growth depends greatly on angiogenesis during the estrous cycle. Endometrial vasculature changes are required to meet the nutrient and oxygen demands for endometrial gland function and embryo survival. PGs are considered as angiogenic factors [39] [40] [41] . In fact, PGE 2 plays a role in promoting angiogenesis [39] and affecting vascular endothelial growth factor (VEGF) in porcine endometrial stromal cells [42] . PGE 2 affects the increase of VEGFs, angiopoietin-1 and angiopoietin-2, secretion, which stimulate angiogenesis by acting on endothelial cells to cause vessel sprouting and tubular structure formation [39, 40] . If we take into consideration that the basal secretion of PGE 2 secretion decreased in category III endometrium compared to category I, it may be assumed that serious alteration occurred in the described PG synthesis.
There are many studies showing the role of cytokines during the process of embryo implantation. Various factors, including cytokines, growth factors, homeobox transcription factors, and PG participate in embryo implantation through autocrine/ paracrine, and/or juxtacrine mechanisms [43] . Haneda et al. [17] showed an increase of endometrial IL1a and IL6 mRNA transcription on Day 25 of pregnancy in the mare, together with an upward tendency in IL1b mRNA transcription. These results suggest that, in the mare, as well as in other species, the cytokines have a functional role in the endometrium during the peri-implantation period [17, 44] . The role of these ILs is best known in humans and mice. IL1a and IL1b are involved in production of leukemia inhibitory factor [45] , granulocytemacrophage colony-stimulating factor, and colony stimulating factor-1 [46] , and in expression of PTGS-2 changes [47] . Additionally, it was established that the PTGS-2 gene knockout INTERLEUKIN IN EQUINE ENDOMETROSIS in mice causes multiple failures in implantation [48, 49] . In turn, the concentrations of PGs are elevated in the areas of increased endometrial vascular permeability associated with the initiation of implantation [50, 51] . Taking into consideration the increase of IL1, IL6 [17] , and the expression of PGs [52] during the peri-implantation period in the mare endometrium, it may be inferred that alterations of their expression may contribute to embryo loss in the presence of endometrosis. However, further in vitro and in vivo studies are needed to confirm this hypothesis.
In conclusion, the data presented should be considered from many points of view. These results give a perspective both in terms of physiological and pathological conditions. First, we have shown that IL expression changed strikingly during the estrous cycle. Second, the ILs studied affect PG production in the endometrium via PG synthases, which may be one of the potential mechanisms regulating the estrous cycle as well as early pregnancy. Third, significant alterations in ILs and the expression of their receptors occurred simultaneously with the development of endometrosis during the estrous cycle. Fourth, these results confirm that, likewise, the alterations in endometrial secretory function are occurring during the progression of endometrosis. The stimulatory effect of ILs on luteotropic PGE 2 secretion was inhibited in category II endometrosis. All of these disturbances can overlap and impair endometrial processes, starting with estrous cycle regulation or local interaction and ending with implantation. Additionally, it is especially worth mentioning that current knowledge concerning the cause of implantation failure in endometrosis is insufficient. The results reported here should contribute to the advance in our understanding of the endometrial changes during endometrosis and the mechanisms responsible for them.
